Moderna Secures Third EU-Authorized Vaccine With mNEXSPIKE, Supporting Protection Against Endemic COVID-19 As European Market Reopens In 2026

Moderna -4.61% Pre

Moderna

MRNA

53.39

53.59

-4.61%

+0.37% Pre

mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via